Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00980980 · ClinicalTrials.gov registry record · NA

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)

A NA study of Methicillin-resistant Staphylococcus Aureus, sponsored by Harvard Pilgrim Health Care.

Completed
Registry status
NA
Development phase
74,256
Enrollment target
20
Study locations

NCT00980980 is a NA study of Methicillin-resistant Staphylococcus Aureus that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 74,256 participants, above the 1,054-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (6945% higher). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00980980, a NA study of Methicillin-resistant Staphylococcus Aureus, has completed, sponsored by Harvard Pilgrim Health Care.

COMPLETED
Registry status
NA
Development phase
74,256 participants
Enrollment target
20
Study locations

Study Summary

The Randomized Evaluation of Decolonization versus Universal Clearance to Eliminate MRSA (REDUCE MRSA) Trial is a cluster randomized trial of the comparative effectiveness of three strategies to prevent methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units. The three strategies to be evaluated are: * screening on admission followed by isolation of MRSA+ patients * screening on admission followed by isolation and decolonization of MRSA+ patients * universal decolonization on admission with no screening. The decolonization regimen involves bathing with chlorhexidine plus intra-nasal application of mupirocin. The main outcome will be MRSA+ clinical cultures. The study is a partnership between the CDC, the CDC Prevention Epicenters, and the Hospital Corporation of America.

Conditions Studied

Methicillin-resistant Staphylococcus Aureus

Interventions

  • DRUG Chlorhexidine bath and nasal mupirocin

Study Locations (20)

Florida

  • Blake Medical Center - Brandenton
  • Brandon Hospital - Brandon
  • Columbia Hosp Corp S Broward (Westside) - Fort Lauderdale
  • Palms West Hospital - Fort Lauderdale
  • Plantation General - Fort Lauderdale
  • Regional Med Cr Bayonet Point - Hudson
  • Largo Medical Center - Largo
  • Community Hospital - New Port Richey
  • Orange Park Med Ctr - Orange Park
  • Fawcett Memorial Hospital - Port Charlotte
  • Doctors Hospital of Sarasota - Sarasota
  • South Bay Hospital - Sun City Center
  • Capital Regional Med Ctr - Tallahassee

Georgia

  • Coliseum (Macon) Northside - Macon
  • Coliseum Medical Center - Macon
  • Cartersville Medical Center - Tucker

Alaska

  • Alaska Regional - Anchorage

California

  • Los Robles Hosp & Med Ctr - Thousand Oaks

Colorado

  • The Medical Center of Aurora - Aurora

Idaho

  • Eastern Idaho Reg Med Ctr - Idaho Falls

Trial Details

FieldValue
Enrollment Target 74,256 participants
Start Date 2009-09
Est. Completion 2011-09
Phase NA

Sponsor

Harvard Pilgrim Health Care

28 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00980980

The ClinicalTrials.gov registry entry for NCT00980980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74,256 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,054-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (6945% higher). The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Methicillin-resistant Staphylococcus Aureus appearing as the primary indexed condition, and to 1 intervention - of which Chlorhexidine bath and nasal mupirocin is the first listed.

NCT00980980 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, Georgia, Alaska.

Frequently Asked Questions

What is clinical trial NCT00980980 about?

NCT00980980 is a clinical study titled "Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)". The Randomized Evaluation of Decolonization versus Universal Clearance to Eliminate MRSA (REDUCE MRSA) Trial is a cluster randomized trial of the comparative effectiveness of three strategies to prevent methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units. The three strategies ...

What is the current status of trial NCT00980980?

This trial is currently completed. It is a NA study. The enrollment target is 74,256 participants. The study started on 2009-09. Estimated completion is 2011-09.

What conditions does trial NCT00980980 study?

This clinical trial studies the following conditions: Methicillin-resistant Staphylococcus Aureus.

What interventions are being tested in trial NCT00980980?

The interventions under investigation include: Chlorhexidine bath and nasal mupirocin (DRUG).

Who is sponsoring clinical trial NCT00980980?

This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00980980 being conducted?

This trial has 20 study locations across Alaska, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Methicillin-resistant Staphylococcus Aureus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Methicillin-resistant Staphylococcus Aureus

All registered trials for this condition

Alaska

All trials with a study site in Alaska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.